Illumina

Director - General Manager, Canada

British Columbia, Canada

$250,000 – $350,000Compensation
Senior (5 to 8 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Life Sciences, HealthcareIndustries

Position Overview

  • Location Type: Remote
  • Employment Type: Full-time
  • Salary: Not specified

Illumina is expanding access to genomic technology to realize health equity for billions of people around the world. Our efforts enable life-changing discoveries that are transforming human health through the early detection and diagnosis of diseases and new treatment options for patients. Working at Illumina means being part of something bigger than yourself. Every person, in every role, has the opportunity to make a difference. Surrounded by extraordinary people, inspiring leaders, and world-changing projects, you will do more and become more than you ever thought possible.

This role is for the General Manager, Canada Sub-Region, responsible for setting the strategic direction of the sub-region (Canada) and ensuring alignment of all Illumina functions. This leader will be one of seven General Managers driving Illumina’s business in the Americas (Canada, Latin America, and United States).

Reports To:

  • AMR Head of Region

Direct Reports:

  • District Sales Managers
  • Sales Specialists Managers

Key Relationships:

  • Part of the AMR Commercial Leadership Team, inclusive of 7 General Managers (5 for US, 1 for CAN, 1 for LATAM), Commercial Ops Leader, Marketing Leader, and Strategic Growth Leader

Requirements

  • Strategic leadership skills
  • Experience in driving business success
  • Understanding of the genomics market
  • Ability to lead and manage teams

Responsibilities

  • Leads Canada business through a team of direct customer-facing functions: district sales and sequencing sales specialists.
  • Responsible for aligning and leveraging execution resources across commercial functions to maximize market adoption and success.
  • Responsible for attainment of financial and strategic goals for the business within the geography in support of the company’s overall financial and strategic objectives.
  • Drive accelerated and consistent revenue growth and market penetration in both life sciences and clinical market businesses.
  • Lead and drive the genomics ecosystem within the region by being responsible for developing commercial plans for advancing the company’s products and/or services to meet market demands within the geographic area of responsibility, working within the general financial plans provided by global commercial management and cross-functional counterparts.
  • Within the geography, directs the sales of the organization’s products or services and develops the country/region’s go-to-market strategy in partnership with marketing and forecasts.

Application Instructions

  • Not specified in the provided text. (Please refer to Illumina's website for application details)

Company Information

  • Company: Illumina
  • Mission: Expanding access to genomic technology to realize health equity for billions of people around the world.

Skills

Strategic Leadership
Business Development
Genomics Market
Team Management
Revenue Growth
Market Penetration
Go-to-Market Strategy

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI